510(k) required for Utah Medical Products' Cordguard II:
This article was originally published in Clinica
Executive Summary
The US CDRH has advised Utah Medical Products (US) that it will have to submit new 510(k) premarketing submission for its new version of Cordguard I. Utah Medical had intended to begin sales of the Cordguard II device later this month but decided to check with the agency that the modified device did not require regulatory clearance. The CRDH informed the company on September 20th that it needs formal documentation that the device is substantially equivalent to the original device. Cordguard II has been designed to reduce clinician exposure to potentially infected blood splatters while collecting neonatal blood samples for diagnosis.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.